These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15663178)

  • 1. Influences of different therapy protocols for chronic hepatitis B infection in Turkish children on nutritional anthropometric data.
    Ozturk Y; Arli AO; Arslan N; Bekem O; Hizli S; Buyukgebiz B
    J Health Popul Nutr; 2004 Dec; 22(4):443-4. PubMed ID: 15663178
    [No Abstract]   [Full Text] [Related]  

  • 2. [The assessment of nutritional status in children with chronic hepatitis B treated with interferon alpha].
    Lebensztejn DM; Zagórecka E; Kaczmarski M; Piotrowska-Jastrzebska J
    Pol Merkur Lekarski; 2001 Jul; 11(61):29-31. PubMed ID: 11579826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 4. Tolerance of interferon-alpha therapy in children with chronic hepatitis B.
    Liberek A; Łuczak G; Korzon M; Szlagatys-Sidorkiewicz A; Bako W; Góra-Gebka M; Rytlewska M; Sikorska-Wiśniewska G
    J Paediatr Child Health; 2004; 40(5-6):265-9. PubMed ID: 15151579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thyrotoxicosis due to long-term therapy with interferon alpha in the patient with mixed chronic active hepatitis B and C].
    Vortel J; Bures J; Rejchrt S; Zivný P; Palicka V
    Vnitr Lek; 1999 May; 45(5):301-4. PubMed ID: 15641255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional status of children with chronic hepatitis B in a population with low socioeconomic status.
    Bekem Soylu O; Targan S; Diniz G; Ortac R
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1252-5. PubMed ID: 19458532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in children with chronic hepatitis B infection and the influence of interferon alpha.
    Kansu A; Kuloğlu Z; Demirçeken F; Girgin N
    Turk J Gastroenterol; 2004 Dec; 15(4):213-8. PubMed ID: 16249973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Interferon-α and Combined Interferon-α with Lamivudine Treatment on Anthropometric Measurements in Children with Chronic Hepatitis B.
    Urganci N; Kalyoncu D; Erdem Eralp E
    Ann Nutr Metab; 2017; 71(1-2):8-9. PubMed ID: 28624823
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term prognosis of interferon nonresponder children with hepatitis B.
    Koçak N; Gürakan F; Saltik IN; Ozen H; Yüce A
    Am J Gastroenterol; 2000 Jul; 95(7):1841. PubMed ID: 10926001
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic viral hepatitis].
    Pedersen C; Pedersen CR
    Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive factors and virological response to interferon treatment in children with chronic hepatitis B.
    Söderström A; Lindh M; Ekholm K; Conradi N; Horal P; Krantz M; Hultgren C; Norkrans G
    Scand J Infect Dis; 2005; 37(1):40-7. PubMed ID: 15764189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of chronic hepatitis B in children.
    Jonas MM
    J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S56-60. PubMed ID: 16819403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term therapeutic efficacy of lamivudine compared with interferon-alpha in children with chronic hepatitis B: the younger the better.
    Choe BH; Lee JH; Jang YC; Jang CH; Oh KW; Kwon S; Hyun MC; Ko CW; Lee KS; Lee WK
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):92-8. PubMed ID: 17204960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal side effects of interferon-alpha therapy in children with chronic hepatitis B infection.
    Ozkan T; Sağlam H
    Turk J Gastroenterol; 2007 Jun; 18(2):126-8. PubMed ID: 17602364
    [No Abstract]   [Full Text] [Related]  

  • 15. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.
    d'Alteroche L; Majzoub S; Lecuyer AI; Delplace MP; Bacq Y
    J Hepatol; 2006 Jan; 44(1):56-61. PubMed ID: 16223542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyrotoxic hypokalemic periodic paralysis as the first manifestation of interferon-alpha-induced Graves disease.
    Cesur M; Gursoy A; Avcioglu U; Erdogan MF; Corapcioglu D; Kamel N
    J Clin Gastroenterol; 2006 Oct; 40(9):864-5. PubMed ID: 17016146
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of interferon and lamivudine treatment in Japanese patients with HBeAg positive chronic hepatitis B.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
    J Med Virol; 2007 Sep; 79(9):1286-92. PubMed ID: 17607775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-alpha therapy: correlation with specific IgG subclass responses to HBsAg.
    Gregorek H; Dzierzanowska-Fangrat K; Woynarowski M; Jóźwiak P; Witkowska-Vogtt E; Socha J; Syczewska M; Madaliński K
    J Hepatol; 2005 Apr; 42(4):486-90. PubMed ID: 15763334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of viral replication in children with chronic hepatitis B with and without interferon treatment.
    Lazăr C; Grigorescu-Sido P; Manasia R; Mireştean S; Skorka C; Neculoiu D; Molnar G; Cocean S
    Rom J Gastroenterol; 2005 Sep; 14(3):219-24. PubMed ID: 16200230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined lamivudine/interferon-alpha treatment in "immunotolerant" children perinatally infected with hepatitis B: a pilot study.
    D'Antiga L; Aw M; Atkins M; Moorat A; Vergani D; Mieli-Vergani G
    J Pediatr; 2006 Feb; 148(2):228-233. PubMed ID: 16492434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.